Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Moon

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|February 1, 1979
Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trialD S Alberts, R D Hilgers, T E Moon, et al.
Cancer Treatment Reports|November 1, 1979
1-year followup of cardiac status after adriamycin therapyM J Friedman, G A Ewy, S E Jones, et al.
Clinical and Experimental Immunology|January 11, 1976
IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemiaW H Dietz, O Porcell, T E Moon, et al.
British Journal of Cancer|April 1, 1980
Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administrationY M Peng, D S Alberts, H S Chen, et al.
Cancer Treatment Reports|September 1, 1977
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology GroupC A Coltman, J K Luce, E M McKelvey, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Oral melphalan kineticsD S Alberts, S Y Chang, H S Chen, et al.
Cancer|September 15, 1988
Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I diseaseF L Meyskens, D H Berdeaux, B Parks, et al.
Cancer|December 1, 1980
Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapyC H Nash, S E Jones, T E Moon, et al.
Cancer Research|February 11, 1998
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinomaE D Bischoff, M M Gottardis, T E Moon, et al.
Critical Care Medicine|March 1, 1980
Influence of time and therapy on ventricular defibrillation in dogsR W Yakaitis, G A Ewy, C W Otto, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|February 1, 1979
Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trialD S Alberts, R D Hilgers, T E Moon, et al.
Cancer Treatment Reports|November 1, 1979
1-year followup of cardiac status after adriamycin therapyM J Friedman, G A Ewy, S E Jones, et al.
Clinical and Experimental Immunology|January 11, 1976
IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemiaW H Dietz, O Porcell, T E Moon, et al.
British Journal of Cancer|April 1, 1980
Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administrationY M Peng, D S Alberts, H S Chen, et al.
Cancer Treatment Reports|September 1, 1977
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology GroupC A Coltman, J K Luce, E M McKelvey, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Oral melphalan kineticsD S Alberts, S Y Chang, H S Chen, et al.
Cancer|September 15, 1988
Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I diseaseF L Meyskens, D H Berdeaux, B Parks, et al.
Cancer|December 1, 1980
Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapyC H Nash, S E Jones, T E Moon, et al.
Cancer Research|February 11, 1998
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinomaE D Bischoff, M M Gottardis, T E Moon, et al.
Critical Care Medicine|March 1, 1980
Influence of time and therapy on ventricular defibrillation in dogsR W Yakaitis, G A Ewy, C W Otto, et al.
Pageof 11